145 related articles for article (PubMed ID: 29193344)
61. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
Du X; He J
Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
[TBL] [Abstract][Full Text] [Related]
62. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
Geng H; Chen W; Xu ZP; Qian G; An J; Zhang H
Chemistry; 2017 Aug; 23(45):10878-10885. PubMed ID: 28580592
[TBL] [Abstract][Full Text] [Related]
63. Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.
Paris JL; Cabañas MV; Manzano M; Vallet-Regí M
ACS Nano; 2015 Nov; 9(11):11023-33. PubMed ID: 26456489
[TBL] [Abstract][Full Text] [Related]
64. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
65. Highly selective and sensitive detection of glutathione using mesoporous silica nanoparticles capped with disulfide-containing oligo(ethylene glycol) chains.
El Sayed S; Giménez C; Aznar E; Martínez-Máñez R; Sancenón F; Licchelli M
Org Biomol Chem; 2015 Jan; 13(4):1017-21. PubMed ID: 25482517
[TBL] [Abstract][Full Text] [Related]
66. Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo.
Zheng H; Wen S; Zhang Y; Sun Z
PLoS One; 2015; 10(10):e0140265. PubMed ID: 26451735
[TBL] [Abstract][Full Text] [Related]
67. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
68. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
69. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
70. Hollow spherical mesoporous phosphosilicate nanoparticles as a delivery vehicle for an antibiotic drug.
Das SK; Bhunia MK; Chakraborty D; Khuda-Bukhsh AR; Bhaumik A
Chem Commun (Camb); 2012 Mar; 48(23):2891-3. PubMed ID: 22310528
[TBL] [Abstract][Full Text] [Related]
71. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
[TBL] [Abstract][Full Text] [Related]
72. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
73. Neoglycoenzyme-Gated Mesoporous Silica Nanoparticles: Toward the Design of Nanodevices for Pulsatile Programmed Sequential Delivery.
Díez P; Sánchez A; de la Torre C; Gamella M; Martínez-Ruíz P; Aznar E; Martínez-Máñez R; Pingarrón JM; Villalonga R
ACS Appl Mater Interfaces; 2016 Mar; 8(12):7657-65. PubMed ID: 26966914
[TBL] [Abstract][Full Text] [Related]
74. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
75. Capped Mesoporous Silica Nanoparticles for the Selective and Sensitive Detection of Cyanide.
Sayed SE; Licchelli M; Martínez-Máñez R; Sancenón F
Chem Asian J; 2017 Oct; 12(20):2670-2674. PubMed ID: 28941199
[TBL] [Abstract][Full Text] [Related]
76. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
[TBL] [Abstract][Full Text] [Related]
77. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
78. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
79. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
80. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
Hu JJ; Xiao D; Zhang XZ
Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
